Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging

Clinical Nuclear Medicine

Volumn 23, Issue 8, 1998, Pages 505-508

  Shih, Wei Jen ^a   Rastogi, Amita ^b   Stipp, Vikie ^b   Magoun, Sylvia ^b   Coupal, John ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chemotherapy; Mediastinal Lymphoma; P glycoprotein; SPECT; Tc 99m MIBI

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DIAGNOSTIC IMAGING; HODGKIN DISEASE; HUMAN; MALE; MEDIASTINUM MASS; MULTIDRUG RESISTANCE; NONHODGKIN LYMPHOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX SCINTISCANNING; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR REGRESSION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031714635     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199808000-00002     Document Type: Article

References (14)

1. Aktolun C, Bayhan H, Pabuccu Y, Bilgie H, Acar H, Koylu R: Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with Tc-99m MIBI imaging comparison with CT scan. Eur J Nucl Med 21:973, 1994.
2. O'Tuama LA, Packard AB, Treves ST: SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium(I). J Nucl Med 31:2040, 1990.
3. Caner B, Kitapci M, Anas T, et al: Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in osteosarcoma and its metastatic lymph nodes J Nucl Med 32:1977, 1991.
4. Shih WJ, Kadzielawa K, Lee C, Moody EB, Ryo UY: Tc-99m MIBI uptake by cerebellar metastasis from bronchogenic carcinoma. Clin Nucl Med 18:887, 1993.
5. Khalkhali, Villanueva-Meyer J, Edell SL, et al: Diagnostic accuracy of Tc-99m sestamibi breast cancer detection. J Nucl Med 37:74p, 1996.
6. Piwnica-Worms D, Holman BL: Noncardiac applications of hexakis (alkylisonitrile) Tc-99m complexes. J Nucl Med 31: 1161, 1990.
7. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al: Uptake of the cation hexakis (2-methoxyisobutyl-isonitrile)-Tc-99m by human carcinoma cell lines in vitro. Cancer Res 50:2198, 1990.
8. Chiu ML, Kronauge JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxybutylisonitrile) Tc-99m in cultured mouse fibroblasts. J Nucl Med 31:1646, 1990.
9. Del Vecchio S, Ciarmiello A, Potena MI, et al: In vivo detection of multidrug-resistant (MDR1) phenotype by Tc-99m MIBI scan in untreated breast cancer patients. Eur J Nucl Med 24:150, 1997.
10. Ciarmiello A, Del Vecchio S, Carriero MV, et al: Efflux rate of Tc-99m MIBI as a predictor of the outcome of therapy in patients with advanced breast carcinoma. J Nucl Med 38:241p, 1997.
11. Del Vecchio S, Ciarmiello A, Pace L, et al: Functional retention of Tc-99m MIBI as an index of p-glycoprotein expression in untreated breast cancer patients. J Nucl Med 38:1348, 1997.
12. Piwnica-Worms D, Chiu ML, Budding M, et al: Functional imaging of multidrug-resistant p-glycoprotein with an organotechnetium complex. Cancer Res 53:977, 1993.
13. Morette JL, Azaloux H, Biosseron D, et al: Primary breast cancer imaging with Tc-99m sestamibi and its relation with p-glycoprotein overexpression. Eur J Nucl Med 23:980, 1966.
14. Bom HS, Kim YC, Song JY, et al: Tc-99m MIBI in small cell lung cancer: A predictor of response to chemotherapy. J Nucl Med 37:67p, 1996.